Increased efficiency for performing colony formation assays in 96-well plates: Novel applications to combination therapies and high-throughput screening

BioTechniques

Volumn 44, Issue 2, 2008, Pages 9-14

  Katz, David ^a,b   Ito, Emma ^a,b   Lau, Ken S ^a,c   Mocanu, Joseph D ^a,b   Bastianutto, Carlo ^a,b   Schimmer, Aaron D ^a,b   Liu, Fei Fei ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ARTICLE; DOSE RESPONSE; DRUG SCREENING; HUMAN; INSTRUMENTATION; METHODOLOGY; MOLECULAR LIBRARY; MULTIMODALITY CANCER THERAPY; RADIATION RESPONSE; REPRODUCIBILITY; STANDARD; TUMOR CELL LINE;

CELL LINE, TUMOR; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; REPRODUCIBILITY OF RESULTS; SMALL MOLECULE LIBRARIES; TUMOR STEM CELL ASSAY;

EID: 47149104497     PISSN: 07366205     EISSN: 19409818     Source Type: Journal    
DOI: 10.2144/000112757     Document Type: Article

References (30)

1. Puck, T.T. and P.I. Marcus. 1956. Action of x-rays on mammalian cells. J. Exp. Med. 103:653-666.
2. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184:39-51.
3. Muir, D., S. Varon, and M. Manthorpe. 1990. An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures. Anal. Biochem. 185:377-382.
4. Bassaneze, V., A.A. Miyakawa, and J.E. Krieger. 2008. A quantitative chemiluminescent method for studying replicative and stress-induced premature senescence in cell cultures. Anal. Biochem. 372:198-203.
5. Pignon, J.P., J. Bourhis, C. Domenge, and L. Designe. 2000. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949-955.
6. Dillman, R.O., S.L. Seagren, K.J. Propert, J. Guerra, W.L. Eaton, M.C. Perry, R.W. Carey, E.F. Frei 3rd, and M.R. Green. 1990. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N. Engl. J. Med. 323:940-945.
7. Stupp, R., W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, et al. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352:987-996.
8. Rose, P.G., B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, M.A. Maiman, D.L. Clarke-Pearson, and S. Insalaco. 1999. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340:1144-1153.
9. Jakse, G., E. Fritsch, and H. Frommhold. 1987. Hyperfractionated, accelerated radio therapy and concurrent chemotherapy in locally advanced bladder cancer. Eur. Urol. 13:22-25.
10. Wouters, B.G., A.J. Giaccia, N.C. Denko, and J.M. Brown. 1997. Loss of p21Waf1/ Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res. 57:4703-4706.
11. Stockwell, B.R. 2000. Chemical genetics: ligand-based discovery of gene function. Nat. Rev. Genet. 1:116-125.
12. Wani, M.C., H.L. Taylor, M.E. Wall, P. Coggon, and A.T. McPhail. 1971. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93:2325-2327.
13. Druker, B.J. and N.B. Lydon. 2000. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J. Clin. Invest. 105:3-7.
14. Shah, N.P., C. Tran, F.Y. Lee, P. Chen, D. Norris, and C.L. Sawyers. 2004. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 305:399-401.
15. Makarenkov, V., D. Kevorkov, P. Zentilli, A. Gagarin, N. Malo, and R. Nadon. 2006. HTS-Corrector: software for the statistical analysis and correction of experimental high throughput screening data. Bioinformatics 22:1408-1409.
16. Giannini, F., R. Maestro, T. Vukosavljevic, F. Pomponi, and M. Boiocchi. 1997. Alltrans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use. Int. J. Cancer 70:194-200.
17. Wylie, P.G. and W.P. Bowen. 2007. Determination of cell colony formation in a high-content screening assay. Clin. Lab. Med. 27:193-199.
18. Simons, A.L., M.A. Fath, D.M. Mattson, B.J. Smith, S.A. Walsh, M.M. Graham, R.D. Hichwa, J.M. Buatti, et al. 2007. Enhanced response of human head and neck cancer xenograft tumors to cisplatin combined with 2-deoxy-d-glucose correlates with increased (18)F-FDG uptake as determined by PET imaging. Int. J. Radiat. Oncol. Biol. Phys. 69:1222-1230.
19. Steel, G.G. and M.J. Peckham. 1979. Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity. Int. J. Radiat. Oncol. Biol. Phys. 5:85-91.
20. Fertil, B., H. Dertinger, A. Courdi, and E.P. Malaise. 1984. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat. Res. 99:73-84.
21. Chou, T.C. and P. Talalay. 1984. Quantitative analysis of dose-effect relation ships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22:27-55.
22. Yip, K.W., E. Ito, X. Mao, P.Y. Au, D.W. Hedley, J.D. Mocanu, C. Bastianutto, A. Schimmer, and F.F. Liu. 2006. Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent. Mol. Cancer Ther. 5:2234-2240.
23. Yip, K.W., X. Mao, P.Y. Au, D.W. Hedley, S. Chow, S. Dalili, J.D. Mocanu, C. Bastianutto, et al. 2006. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen. Clin. Cancer Res. 12:5557-5569.
24. Keshelava, N., T. Frgala, J. Krejsa, O. Kalous, and C.P. Reynolds. 2005. DIMSCAN: a microcomputer fluorescence based cytotoxicity assay for preclinical testing of combination chemotherapy. Methods Mol. Med. 110:139-153.
25. Forster, F., A. Volz, and G. Fricker. 2007. Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system. Eur. J. Pharm. Biopharm. Oct 9 [Epub ahead of print].
26. Ghosh, R.N., R. DeBiasio, C.C. Hudson, E.R. Ramer, C.L. Cowan, and R.H. Oakley. 2005. Quantitative cell-based high-content screening for vasopressin receptor agonists using transfluor technology. J. Biomol. Screen. 10:476-484.
27. Brideau, C., B. Gunter, B. Pikounis, and A. Liaw. 2003. Improved statistical methods for hit selection in high-throughput screening. J. Biomol. Screen. 8:634-647.
28. Bellosillo, B., D. Colomer, G. Pons, and J. Gil. 1998. Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B-chronic lymphocytic leukaemia cells. Br. J. Haematol. 100:142-146.
29. Borchmann, P., K. Hubel, R. Schnell, and A. Engert. 1997. Idarubicin: a brief overvie on pharmacology and clinical use. Int. J. Clin. Pharmacol. Ther. 35:80-83.
30. Himes, R.H., R.N. Kersey, I. Heller-Bettinger, and F.E. Samson. 1976. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res. 36:3798-3802.